SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-115450
Filing Date
2024-04-26
Accepted
2024-04-26 06:10:24
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A d717381ddefa14a.htm DEFA14A 17207
2 GRAPHIC g717381g02m01.jpg GRAPHIC 8644
3 GRAPHIC g717381g02m02.jpg GRAPHIC 24966
4 GRAPHIC g717381g02m03.jpg GRAPHIC 61155
5 GRAPHIC g717381g02m04.jpg GRAPHIC 109106
6 GRAPHIC g717381g03m00.jpg GRAPHIC 8727
  Complete submission text file 0001193125-24-115450.txt   311358
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39866 | Film No.: 24878426
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)